Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patent settlements
Pharma
Axsome bars generic rivals to narcolepsy med Sunosi until 2040
The company inked another settlement with a prospective generic maker, leaving no further pending patent litigation for its Sunosi on the table.
Zoey Becker
Jun 4, 2026 9:35am
Gilead inks Biktarvy settlements with 3 generic drug makers
Oct 7, 2025 7:40am
AbbVie settles lawsuit to ward off Rinvoq generics until 2037
Sep 11, 2025 1:36pm
GSK nabs $320M in CureVac patent settlement
Aug 8, 2025 10:46am
China biotech deals, Takeda, LaNova—Fierce Pharma Asia
Jul 18, 2025 9:04am
Teva agrees with Axsome to keep generic off market until 2038
Feb 10, 2025 11:28am
